Join the Oncology Voice Network. Join for Free
The OVERLOOKED KOL
Advanced Practice Providers Medical Science Liaison Key Opinion Leaders Physician Assistants Nurse Practitioners

The OVERLOOKED KOL


Share This Article


Summary

In this episode, Tom Caravela hosts Leticia Price and Dawn O'Reilly to discuss the critical role of Advanced Practice Providers (APPs) in the medical field. They explore the educational backgrounds and capabilities of APPs, emphasizing their often underutilized potential as Key Opinion Leaders (KOLs). Strategies for effectively identifying and engaging APPs are shared, along with advice for Physician Assistants (PAs) and Nurse Practitioners (NPs) transitioning to Medical Science Liaison (MSL) roles. The conversation highlights the importance of networking, resource utilization, and effective time management. The episode concludes with insights into the value of APPs in medical progress and territory planning.

My guests this week are Medical Science Liaisons, Dawn O'Reilly and Letitia Price, who discuss the benefits of Medical Science Liaisons engaging with Advanced Practice Providers.

Learn more about…

πŸ‘‰ What are APPs
πŸ‘‰ Why should MSLs be calling on APPs
πŸ‘‰ How can an NP or PA transition to industry
πŸ‘‰ Why are NPs and PA’s often overlooked
πŸ‘‰ How can MSLs find success in their territory

Click for Source
Advanced Practice Providers, Medical Science Liaison, Key Opinion Leaders, Physician Assistants, Nurse Practitioners

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Explore OVN